Results 121 to 130 of about 126,252 (309)

New Evidence on Financial Incentives and the Timing of Retirement [PDF]

We investigate the responsiveness of individual retirement decisions to changes in financial incentives. The causal effect is identified based on the natural experiment generated by an institutional reform.
Barbara Hanel, Regina T. Riphahn
core  

Impact of Evolving Treatment Patterns on Interstitial Lung Disease Progression in Systemic Sclerosis Using the European Scleroderma Trials and Research Database

Arthritis &Rheumatology, EarlyView.
Objective The treatment landscape for systemic sclerosis‐associated interstitial lung disease (SSc‐ILD) has evolved with increasingly available immunosuppressive therapies (ISTs) and antifibrotic treatments. However, their real‐world use remains unclear.
Corrado Campochiaro, Marie‐Elise Truchetet, Madelon Vonk, Giacomo De Luca, Giovanna Cuomo, Lidia P. Ananieva, Eric Hachulla, Vanessa Smith, Ana Maria Gheorghiu, Radim Becvar, Patricia Carreira, Nicolas Hunzelmann, Daniel E. Furst, Vera Ortiz‐Santamaria, Francesco Del Galdo, Marco Matucci‐Cerinic, Anna‐Maria Hoffmann‐Vold, EUSTAR collaborators   +17 more
wiley   +1 more source

Can probiotics prevent acute radiation-induced diarrhoea among cervical cancer patients?: the result from a randomized double-blinded placebo-controlled study

, 2018
Ye Htut Linn, K Khine Thu, Nang Hla Hla Win   +2 more
openalex   +2 more sources

Thermachoice III Endometrial Ablation: A Randomized, Double Blind Placebo Controlled Trial of Lower Uterine Block Anesthesia as Post-Operative Pain Management [PDF]

, 2011
Hector O. Chapa, Gonzalo Venegas
openalex   +1 more source

Treatment with L‐Citrulline in patients with post‐polio syndrome: A single center, randomized, double blind, placebo‐controlled trial

, 2021
Niveditha Putananickal, Anna‐Lena Orsini, Simone Schmidt, Vanya Gocheva, Daniela Rubino, Tanja Haas, Sabine Schädelin, Xeni Deligianni, Oliver Bieri, Dirk Fischer, Patricia Hafner   +10 more
openalex   +1 more source

Rheumatoid Arthritis: Early diagnosis and treatment outcomes with individualized Homoeopathic medicine: A single blind, simple randomized placebo controlled study [PDF]

, 2022
Mohanty Niranjan
openalex   +1 more source

Therapeutic HIV-1 Tat vaccination promotes durable immune reconstitution and reservoir reduction in ART-treated adults with clade C infection: a 12-year follow-up study. [PDF]

Front Immunol
Picconi O, Sgadari C, Tripiciano A, Moretti S, Maggiorella MT, Francavilla V, Casabianca A, Orlandi C, Belli R, Palladino C, Campagna M, Mancini F, Sernicola L, Pavone Cossut MR, Pimpinelli F, Magnani M, Ensoli F, Mathebula M, Cafaro A, Monini P, Nchabeleng M, Ensoli B.   +21 more
europepmc   +1 more source

Serum Proteomic Signatures of Rheumatoid Arthritis Risk and Response: Analysis of a Rheumatoid Arthritis Interception Trial

Arthritis &Rheumatology, EarlyView.
Objective Our study objective was to identify serum protein signatures associated with progression to rheumatoid arthritis (RA) and response to abatacept in at‐risk individuals. Methods A total of 440 serum samples from 118 APIPPRA (Arthritis Prevention In the Preclinical Phase of RA with Abatacept) study participants were selected from baseline to RA ...
Marianna Jasenecova, Carl Coyle, Alina Mihalovits, Sarah Ryan, Elizabeth Pook, Esperanza Perucha, Gabrielle Harker, Melody Chin, Sam Norton, Andrew P. Cope   +9 more
wiley   +1 more source

Regarding: "comparative effects of pharmacological interventions in the prophylactic treatment of tension-type headache: systematic review and network meta-analysis". [PDF]

Ann Med
Xu Z, Huang C.
europepmc   +1 more source

Prescribing of Medication to Prevent Glucocorticoid Harms in Patients With Polymyalgia Rheumatica: A Cross‐Sectional Study and Two Emulated Target Trials in the Clinical Practice Research Datalink Aurum

Arthritis &Rheumatology, EarlyView.
Objective Polymyalgia rheumatica (PMR) is a common indication for long‐term glucocorticoid (GC) treatment. Bone‐protective and gastroprotective medications are recommended for those at high risk of adverse events from GCs, but no trials have evaluated their effectiveness in PMR.
Helen Twohig, David Jenkinson, James Bailey, Samantha Hider, Ian C. Scott, Sara Muller   +5 more
wiley   +1 more source